Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.

Sohrabian A, Mathsson-Alm L, Hansson M, Knight A, Lysholm J, Cornillet M, Skriner K, Serre G, Larsson A, Weitoft T, Rönnelid J.

Ann Rheum Dis. 2018 Sep;77(9):1345-1353. doi: 10.1136/annrheumdis-2017-212627. Epub 2018 Jun 12.

2.

Altered levels of exhaled nitric oxide in rheumatoid arthritis.

Thornadtsson A, Lind A, Weitoft T, Högman M.

Nitric Oxide. 2018 Jun 1;76:1-5. doi: 10.1016/j.niox.2018.02.008. Epub 2018 Feb 24.

PMID:
29486306
3.

Seasonal variations of urate in a Swedish adult population.

Åkerblom A, Helmersson-Karlqvist J, Weitoft T, Larsson A.

Clin Rheumatol. 2017 Jul;36(7):1595-1598. doi: 10.1007/s10067-017-3591-z. Epub 2017 Mar 10.

4.

Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.

Weitoft T, Larsson A, Saxne T, Manivel VA, Lysholm J, Knight A, Rönnelid J.

Scand J Rheumatol. 2017 Sep;46(5):346-352. doi: 10.1080/03009742.2016.1244288. Epub 2016 Dec 15.

PMID:
27973973
5.

Active Rheumatoid Arthritis in Central Africa: A Comparative Study Between Sudan and Sweden.

Elshafie AI, Elkhalifa AD, Elbagir S, Aledrissy MI, Elagib EM, Nur MA, Weitoft T, Rönnelid J.

J Rheumatol. 2016 Oct;43(10):1777-1786. Epub 2016 Aug 1.

6.

Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies.

Weitoft T, Larsson A, Manivel VA, Lysholm J, Knight A, Rönnelid J.

Rheumatology (Oxford). 2015 Oct;54(10):1923-8. doi: 10.1093/rheumatology/keu486. Epub 2015 Jun 8.

PMID:
26060322
7.

Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study.

Weitoft T, Rönnelid J, Knight A, Lysholm J, Saxne T, Larsson A.

Arthritis Res Ther. 2014 Jun 20;16(3):R129. doi: 10.1186/ar4586.

8.

Does modern treatment of early rheumatoid arthritis reduce the need for intra-articular glucocorticoids?

Weitoft T, Øberg K.

Scand J Rheumatol. 2013;42(2):163-4. doi: 10.3109/03009742.2012.758776. No abstract available.

PMID:
23441860
9.

Importance of immobilization after intraarticular glucocorticoid treatment for elbow synovitis: a randomized controlled study.

Weitoft T, Forsberg C.

Arthritis Care Res (Hoboken). 2010 May;62(5):735-7. doi: 10.1002/acr.20039.

10.
12.
14.

Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis.

Carlström K, Hedin PJ, Jönsson L, Lerndal T, Lien J, Weitoft T, Axelson M.

Scand J Rheumatol. 2000;29(2):89-94.

PMID:
10777121
15.
16.

Bacterial arthritis in a Swedish health district.

Weitoft T, Mäkitalo S.

Scand J Infect Dis. 1999;31(6):559-61.

PMID:
10680985
17.

Occurrence of polymyositis in the county of Gävleborg, Sweden.

Weitoft T.

Scand J Rheumatol. 1997;26(2):104-6.

PMID:
9137324
18.

Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association.

Hedin PJ, Weitoft T, Hedin H, Engström-Laurent A, Saxne T.

J Rheumatol. 1991 Oct;18(10):1601-5.

PMID:
1765988
19.

Treatment of rheumatoid patients with Proresid.

Lysholm J, Weitoft T.

Scand J Rheumatol. 1990;19(2):170. No abstract available.

PMID:
2336553
20.

[A fatal drug-induced autoimmune syndrome].

Weitoft T, Domeij-Nyberg B.

Lakartidningen. 1989 Sep 27;86(39):3260-1. Swedish. No abstract available.

PMID:
2796512
21.

[Acute gait disorders--an adverse effect of chloroquine].

Weitoft T, Piehl-Aulin K, Domeij B.

Lakartidningen. 1988 Apr 20;85(16):1432-3. Swedish. No abstract available.

PMID:
3361992
22.

Side effects of Proresid in the treatment of chronic arthritis.

Weitoft T, Lysholm J.

Scand J Rheumatol. 1988;17(1):63-6. No abstract available.

PMID:
3368755
23.

Proresid in the long-term treatment of rheumatoid arthritis.

Lysholm J, Weitoft T.

Scand J Rheumatol. 1988;17(6):465-8.

PMID:
3232037

Supplemental Content

Loading ...
Support Center